All strains were screened in Casamino Acids -yeast extract (CAYE) broth supplemented with 1.0 µg/ml ferric chloride (CAYEF medium) for functional CTLT production. In addition, selected C. jejuni strains were screened in (i) Brucella broth supplemented with 0.25 per cent each of L-asparagine, L-serine and L-glutamic acid (BASG broth), (ii) BASG broth supplemented with 0.05 to 0.5 per cent L-cysteine, corn starch, yeast extract and dextrose, and (iii) G-C medium supplemented with 0.1 per cent IsoVitalex (GCIV medium). The effect of polymyxin B on release of CTLT from periplasmic space was studied with cultures grown in GCIV medium. Cultures were grown microaerobically under shaking or stationary conditions at 42°C for 24-48 h.
Selected C. jejuni strains were passaged multiple times through the intestinal loops of Sprague-Dawley rats and the secreted intestinal fluids were tested for the presence of functional toxin. Chinese hamster ovary (CHO) cell elongation assay was used for the detection of functional CTLT. Serial doubling dilutions of bacteria-free culture supernatant were used with a starting dilution of 1:2. In some cases, filtrates were concentrated to 50X by lyophilisation followed by reconstitution and dialysis before testing. Elongation of >50 per cent of the monolayer at a filtrate dilution of ≥1:4 was considered positive for CTLT production.
Serological testes used for the detection of CT crosss-reactive material in the culture filtrates were (i) ganglioside GM1 ELISA in which ELISA plate coated with GM1 ganglioside was reacted with culture supernatant and rabbit polyclonal CT antibody, (ii) direct ELISA in which ELISA plate was directly coated with bacterial sonicate and reacted with CT antibody, and (iii) immunoblot assay in which bacteria-free culture filtrate, crude outer membrane protein (OMP), or sarcosyl-purified OMP was separated by SDS-PAGE, transferred to nitrocellulose membrane and probed with rabbit anti-CT antibody.
The amino acid sequence of the CT cross-reactive band was analysed by matrix-assisted laser desorption ionization-time of flight (MALDI TOF-TOF). The protein identified was further confirmed by immunoblot analysis in which a recombinant C. jejuni PorA protein (fusion protein, GST-PorA expressed from porA gene of C. jejuni strain C31) was checked for its reactivity with rabbit CT polyclonal antibody and vice-versa in which rabbit antibody to recombinant porA was checked for its activity against CT.
Results
None of the filtrates of bacteria grown in different media was positive for CTLT production by the CHO cell assay. Fifty times concentrated culture filtrates from a Swedish strain and the Australian strain tested in this assay were negative. The control ETEC strain used in this assay was positive. The Australian strain and a Kuwaiti strain gave a fluid to loop-length ratio of 0.3 after four rat ileal loop passages. However, the ileal loop fluids did not cause CHO cell elongation. In the GM1 ELISA, CAYE filtrates from two Swedish strains, the Australian strain and 16 Kuwaiti strains were positive 7 .
Numerous strains (both GM1 ELISA positive as well as negative) and the NCTC 11168 strain (a known CT-negative strain) yielded two prominent bands of 78.6 kDa and 53 kDa size on immunoblot with rabbit anti CT antibody. However, when blots were probed with normal rabbit serum, the 78.6 kDa band only . Two strains each of C. coli, C. lari, C. foetus, C. hyointestinalis and C. upsaliensis were negative for CTLT production when culture filtrates from CAYE medium were tested in the CHO cell assay. Immunoblot analysis of crude OMPs revealed a common 53 kDa band for all species and several additional bands (six for C. foetus). When reacted with normal rabbit serum, a common non-specific band of 79 kDa for all species with two additional higher molecular weights for C. upsaliensis were visible. Apart from the 79 kDa non-specific band, the other six bands for C. foetus appeared to be specific. When Sarkosyl-purified OMPs were allowed to react with anti-CT antibody in immunoblot assays, all species (except C. foetus) produced the unique single band of 53 kDa. The purified OMP preparation from C. foetus produced several bands in a ladder-like pattern (C. foetus is known to possess an S-layer OMP which separates into a ladder-like pattern on electrophoresis), as did the crude membrane preparation. However, the nonspecific band of 79 kDa that reacted with normal rabbit serum was absent. When Sarkosyl-purified OMPs were allowed to react with normal rabbit serum in immunoblot assays, no band from any species was visible 8 .
Discussion
There are reported similarities in PorA across many Campylobacter species at genetic and amino acid sequence levels. Therefore, the 53 kDa protein from non-C. jejuni species that cross-reacted with anti CT antibody is likely to be PorA.
Evidence for the production by C. jejuni of an enterotoxin that is structurally and biologically related to CT and LT was based on the following observations: (i) C. jejuni causes morphological alteration and raises intracellular level of cAMP in CHO and Y-1 cells 4, 9 ; (ii) the effects on morphology and cAMP levels in CHO and Y-1 cells are neutralised by antiserum to CT 4, 9 ; (iii) C. jejuni induces fluid secretion in rat ileal loop assay 9, 10 ; (iv) children infected with C. jejuni produce serum antibodies that cross-react with CT and LT [11] [12] [13] ; (v) culture filtrates reacted in GM1 ganglioside ELISA with antiserum to CT or LT 14,15 ; and (vi) galactoside, ganglioside or CT antibody affinity purified material from culture filtrates caused morphological alteration and raised cAMP levels in sensitive cells or reacted in GM1 ganglioside ELISA [15] [16] [17] .
However, a careful appraisal of the literature suggests that there are problems with the assays which gave rise to these findings. For morphological assay using CHO cells, no standard criterion was set for interpreting positive results. Several studies defined elongation of any number of cells (ranging from a few to <50%) as positive for the presence of an enterotoxin 4, [18] [19] [20] . In other studies, either undiluted culture filtrate or filtrate at a dilution of <1:2 was used 4, 21, 22 . In all these studies, the amount of toxin reported to be produced by the isolates was very small. This is contrary to V. cholerae and enterotoxigenic E. coli infections, where the organisms produce large amounts of enterotoxins that result in profuse watery diarrhoea, which is not seen in C. jejuni infection 2 . We believe an accepted criterion for positive test would be a culture filtrate dilution of >1:4 affecting > 50 per cent of the cells. This should rule out nonspecific effects of components in the media, since undiluted or lower dilutions of the media were shown to give false positive results 23 . By this criterion, all strains tested by us were negative. Filtrates of cultures produced in different media that were reported to promote enterotoxin production failed to yield positive results.
Another factor to be considered is the confounding effect of cytolethal distending toxin (CLDT) in the CHO cell assay. Both CT and CLDT cause elongation of cells after 24 h of incubation, but the toxins are distinguished on further incubation of cells. Whereas CLDT causes progressive distention and cytotoxicity of cells over the next four days, such effects are not seen with CT 5 . Many reports on the production of CTLT by C. jejuni appeared before the existence of CLDT was known 9, 20, 24 . It is quite likely that the effect of CLDT would have been confused with that of CTLT.
The amount of cAMP reported to be produced by the C. jejuni isolates in cells is small in comparison to that produced by CT or LT 4, 9 . There is only partial abrogation or no abrogation of the effect of the toxin by anti-CT and anti-LT sera on morphological assay using cell cultures 4, 18 . However, the effect of normal serum on neutralisation of morphological change in these studies is not known. CLDT also induces modest increase in cAMP levels 5 . However, CT and CLDT are antigenically distinct 5 . As reported by others 9, 10 , two of our isolates induced fluid accumulation in rat ileal loop assay, but only after repeated passage. However, as observed in another study 25 , the secreted fluid did not induce elongation of CHO cells, a finding consistent with the notion that fluid secretion was not due to CTLT production. It could be due to other mechanisms such as via inflammatory mediators of secretion 26 .
The evidence put forward to support the production of enterotoxin by C. jejuni was the development of serum antibodies to CT in children in Mexico 13 and Central African Republic 12 who suffered from C. jejuni diarrhoea. However, other studies failed to demonstrate such antibodies 27, 28 or demonstrated a weak antibody response only 11 . It is possible that children showing antibody responses were concomitantly infected with enterotoxigenic E. coli 28 . The reported purification studies of a postulated enterotoxin from C. jejuni have produced confusing results 10, 15, 16, 29 . These studies used ammonium sulphate precipitation, followed by purification with affinity chromatography using galactose, gangliosides or CT antibodies. The purified fractions had either a single band of ~ 70 kDa 15, 17 or multiple bands of 68-, 54-and 43-kDa 16, 30 . In another study, the molecular masses of bands that reacted with anti-CT antibody were > 90 kDa and 50 kDa 29 . Some bands had biological activity 15, 16 while others did not 16, 30 . It is thus difficult to reconcile the findings from different studies. In our immunoblot studies with CT antibody, two bands of 78.6 kDa and 53 kDa were visible. However, the high molecular weight band was due to a non-specific reaction with normal rabbit serum.
Conclusions
We have screened numerous, freshly isolated clinical local strains and also control strains of C. jejuni from various laboratories, which reportedly produced an enterotoxin. In spite of using several media that were reported to promote enterotoxin production by C. jejuni, none of the strains produced any enterotoxin in our hands. Thus our findings are similar to those of several other groups 11, 23, 27, 28 . Other Campylobacter species also did not produce a functional enterotoxin by CHO cell assay in this study. One of the reasons that contributed to the conclusion that C. jejuni and other species produce an enterotoxin resembling CT was the reactivity of culture filtrates with anti-CT antibody in GM1 ELISA. Our results show unequivocally that Campylobacter species possess an antigen that reacts with anti-CT antibody. That antigen is the major outer membrane protein, PorA.
Introduction
Bacteria have immense capability to modulate their gene expression according to various environmental conditions. Among such conditions, nutrient limitation is a critical factor that determines their survival and growth. The adaptive response to nutritional stress in microbial cells leads to rapid and complex metabolic adjustments through modulation of gene expression and regulation, which is widely known as the stringent response 1 . Being an environmental pathogen, Vibrio cholerae, that causes severe diarrhoeal disease cholera, faces several stresses including nutritional scarcity while staying in aquatic bodies as well as in host gastrointestinal tract. In order to survive and grow, the pathogen must sense and adapt to these frequent changes of various factors in their surrounding environment. Thus, the stringent response may play a critical role in survival of this microorganism under stress conditions. The abrupt global changes in gene expression associated with the stringent response are mainly triggered by the intracellular accumulation of two small molecules called guanosine 3′-diphosphate 5′-triphosphate and guanosine 3′,5′-bis(diphosphate), collectively called (p)ppGpp Generally, in Gram-negative γ-proteobacteria the cytoplasmic level of (p)ppGpp is maintained by the products of two genes relA and spoT, called RelA and SpoT, respectively. While (p)ppGpp is synthesized by the RelA enzyme under amino acid starved condition, SpoT hydrolyses it 1 . However, SpoT is a bifunctional enzyme with weak (p)ppGpp synthesizing activity that can synthesize (p)ppGpp under glucose or fatty acid starved condition 1 (Fig. 1) . The biology of stringent response is extensively studied in Escherichia coli. However, recent studies on V. cholerae and also in other bacteria indicate that apart from canonical RelA/ SpoT, these organisms may code for novel (p)ppGpp synthetases. Further, recent studies indicate that an RNA polymerase-associated small regulatory protein, called DksA, and a conserved essential GTP binding protein CgtA are also involved in regulation of stringent response by modulating the activity of (p)ppGpp 1 . Since the RelA and SpoT enzymes of V. cholerae are structurally and functionally very similar to that of E. coli, the present review will primarily focus on RelV, DksA and CgtA proteins.
The relA and spoT genes of V. cholerae
Haralalka et al
2 first demonstrated that like in E. coli, V. cholerae relA gene product is involved in (p)ppGpp synthesis. This is supported by the fact that V. cholerae relA null mutant cells failed to accumulate (p)ppGpp upon amino acid starvation. In E. coli, it has been shown that when the rate of tRNA aminoacylation does not meet the demands of protein synthesis, the ribosome associated RelA is activated 1 . The activated RelA then triggers the stringent response through conversion of GTP to (p)ppGpp, which finally leads to the rapid inhibition of syntheses of stable RNAs, ribosomes, and proteins, and ultimately arrest of cell growth. It is expected that a similar mechanism is operative in V. cholerae cells. However, unlike E. coli, V. cholerae relA mutant showed severe growth defect in M9 minimal (MM) medium lacking amino acids 2, 3 . It is known that wild type E. coli cells can grow in nutritionally poor MM medium due to synthesis of (p)ppGpp, which promotes amino acid biosynthesis operons. Thus, the growth of E. coli relA mutant in M9 medium has been explained due to the (p)ppGpp synthetic activity of SpoT 4 . It is to be noted that like E. coli, V. cholerae also possesses the spoT gene and Das et al 5 showed that the spoT gene is functional in V. cholerae. The growth defect of V. cholerae relA mutant in MM medium even in the presence of functional spoT gene could be due to activation of a gene, which codes for a novel (p)ppGpp synthetase. It appears that, in the absence of RelA, this novel (p) ppGpp synthetase most likely produces a large quantity of (p)ppGpp, which is toxic to cells. 5 have demonstrated that the ACT domain of SpoT protein of V. cholerae is essential for (p)ppGpp hydrolase activity. Since E. coli SpoT has a very similar structure, it is expected that the ACT domain may play similar function in E. coli. Battesti and Bouveret 6 have shown that during fatty acid starvation (p)ppGpp synthetase activity of SpoT is regulated through an interaction of the TGS domain of the enzyme with the acyl carrier protein (ACP), a central co-factor in fatty acid biosynthesis.
Discovery of RelV
While characterizing V. cholerae ∆relA ∆spoT mutants, Das and Bhadra 7 provided evidence that in V. cholerae there is a probable third source of (p) ppGpp synthesis. When they tried to develop a (p) ppGpp 0 strain by deleting relA and spoT, the double mutant still produced sufficient (p)ppGpp under glucose or fatty acid starved condition 5, 7 . In contrast to this observation, E. coli ∆relA ∆spoT mutant is phenotypically a (p)ppGpp 0 strain 1 . Ultimately, Das et al 5 were able to identify the gene relV and showed that apart from relA and spoT, relV is also responsible for the production of (p)ppGpp (Fig. 1) . In fact, relV and (iv) what is the role of the gene in maintaining basal level of (p)ppGpp? Furthermore, deletion of relA and spoT leads to slow growth of V. cholerae cells during lag to log phase in a nutritionally rich medium and the defect is corrected in a relA spoT relV triple mutant indicating that relV is most likely activated in early log phase and leads to high basal level of (p)ppGpp, which is inhibitory to growth 5 . However, at present it is not clear how the relA spoT mutant cells manage to degrade (p) ppGpp in the absence of (p)ppGpp hydrolase enzyme SpoT.
CgtA and stringent response
CgtA is a highly conserved essential GTP-binding protein, coded by the cgtA gene, belonging to Obg subfamily in prokaryotes 8 . CgtA has been suggested to play important roles in various physiological processes, e.g., regulation of initiation of sporulation, DNA replication, chromosome partitioning, replication fork stability, chromosome segregation, ribosome maturation, etc. Recent studies indicate that CgtA is involved in maintaining steady-state level of (p) ppGpp during exponential growth 9 . CgtA was found to be associated with the 50S ribosomal subunit 10 . Crystal structure analysis of the full-length CgtA/ Obg protein from Thermus thermophilus revealed three domains; a central GTP-binding domain flanked by N-and C-terminal domains designated OBG and OCT, respectively that are unique to the Obg protein 11 . Buglino et al 12 showed that (p)ppGpp is bound with G domain in the crystal structure of C-terminally truncated Obg/CgtA protein of B. subtilis and proposed that CgtA/Obg probably recognizes (p)ppGpp in response to starvation or stress. Reports suggest the role of CgtA in stringent response since it has been co-purified with the SpoT protein in E. coli 10 . In the case of V. cholerae, CgtA is an essential protein and has been shown to interact with SpoT 9, 13 . It has been suggested that CgtA most likely modulates the SpoT function for proper maintenance of cellular (p)ppGpp level 9 ( Fig. 1 ).
DksA, a pleiotropic regulator
The dksA gene is highly conserved in Gram-negative bacteria including in V. cholerae. From bioinformatic analysis it appears that the dksA gene of V. cholerae codes for a small protein of ~ 17-kDa in size, which is similar to that of E. coli DksA protein. However, unlike cgtA, dksA is not an essential gene in V. cholerae, since V. cholerae ∆dksA mutant is viable (unpublished observation). This is similar in other bacteria including E. coli, except in Myxococcus xanthus where dksA has been reported to be an essential gene 14 . The dksA gene function was first identified as a dose-dependent multicopy suppressor of temperature sensitivity and filamentation phenotype of a dnaK gene deleted mutant of E. coli 15 . Conservation of dksA in microbial genomes suggests that the product of this gene most likely play important roles in bacterial physiology. The 2.0 Å resolution structure of E. coli DksA has been reported 16 , which revealed a globular domain and coiled coil (consists of two long N-and C-terminal α-helices) structure of the protein. Amino acid sequence alignment of DksA homologues of various Gram-negative bacteria including the DksA protein of V. cholerae indicates that DksA is well conserved, especially its C-terminal half, which contains a potential coiled coil motif with several invariant amino acid residues and a C4-type Zn finger motif 16 (Fig. 2 ).
DksA has pleiotropic functions in bacteria, which include modulation of stringent response [16] [17] [18] , gene expression 19, 20 , quorum sensing 20 and pathogenesis [21] [22] [23] [24] [25] . Among these, modulation of functions of stringent response appears to be important. Several studies have suggested that DksA acts as a co-regulator for the (p)ppGpp-dependent regulation of genes. A dksA mutant strain of E. coli showed auxotrophy that can be suppressed by a rpoB mutation (βT563P), which also suppresses the auxotrophy of a (p) 27 . It has been shown that DksA and (p)ppGpp may exert independent effects on gene transcription under both in vivo and in vitro situations 27 .
DksA belongs to a unusual family of transcriptional regulators which does not bind directly to the regulatory part of a gene, rather it binds directly to the secondary channel of RNA polymerase (RNAP) as shown in the case of E. coli 1, 16 . When DksA binds directly to RNAP, two highly conserved aspartic acid residues of the protein (Fig. 2) help in stabilizing the (p)ppGpp-Mg 2+ -RNAP complex 16 . DksA decreases the half-life of the open complexes formed upon transcription initiation and amplifies the (p)ppGpp effect 16, 18 . The hallmark of the stringent response is downregulation of stable RNA synthesis (rRNAs and tRNAs) and ribosome production under amino acid starvation. In addition to downregulation of stable RNA synthesis, transcription from a number of promoters that control the expression of genes involved in survival and stress adaptation, are also stimulated during stringent response. Not only negative effects of (p)ppGpp are amplified by DksA, the positive influence of DksA in transcription from amino acid biosynthesis gene promoters have also been reported 18, 24 . Thus, it appears that DksA functions as a co-factor for (p)ppGpp by synergistically amplifying the effect of (p)ppGpp depending on specificity of promoters.
Apart from its involvement in stringent response, several studies also indicate that DksA may regulate flagella synthesis in motile bacteria 27, 28 . The ability of bacteria to swim with the help of flagella toward or away from specific environmental stimuli, such as nutrients, oxygen, or obnoxious substances provides cells with a survival advantage, especially under nutrient-limiting conditions. Flagella synthesis during stationary phase and after starvation was found to be inhibited by DksA and (p)ppGpp. This role of DksA not only co-ordinates ribosome assembly and flagella synthesis but also prevents expenditure of limited energy resources on two of the cell's intense energy demanding processes of macromolecular synthesis 28 . From mutational studies, it appears that DksA is involved in motility of V. cholerae 29 ( Fig. 1) , an important phenotype of this human pathogen, which is considered important for pathogenesis.
A growing number of recent studies indicate involvement of DksA in processes related to growth, stress, starvation, and survival that eventually affect the pathogenic potential of a bacterium. A common scenario is that when DksA is absent, pathogenicity is compromised for reasons that vary with the organism studied. Inhibitory effects can also occur on host interactions that enhance pathogen survival, invasiveness, or persistence. Examples include Salmonella enterica serovar Typhimurium, Shigella flexneri, Pseudomonas aeruginosa, Campylobacter jejuni, E. coli and V. cholerae. In S. enterica serovar Typhimurium, dksA gene product controls the expression of the stationary phase sigma factor rpoS (σ 38 ) and as a result dksA mutant was less virulent than the parental strain when tested in mice as well as in 3-week-old hatched chickens 25 . In S. flexneri, DksA is involved in intracellular spread upon infection of epithelial cell layers 24 . Unlike in Salmonella, the effect of DksA does not depend on the sigma factor RpoS in S. flexneri 22 . In P. aeruginosa, the las and rhl quorum sensing systems control the secretion of extracellular virulence factors including rhamnolipids and LasB elastase 21 . DksA is also involved in posttranscriptional control of the extracellular virulence factor production in P. aeruginosa. In C. jejuni, dksAlike protein exhibited a decreased ability to invade intestinal cells and induced release of interleukin-8 from intestinal cells 20 . Similarly, it has been reported that adherence capacity of enterohaemorrhagic E. coli and gene expression in the locus of enterocyte effacement are modulated by (p)ppGpp and DksA 23 . Interestingly, in V. cholerae significant reduction of cholera toxin production, its principal virulence factor was observed under in vitro condition 29 . Recently, Mueller et al 30 reported that mutation of dksA is probably responsible for indole non-responsive phenotype in V. cholerae (Fig. 1 ). Indole is a natural breakdown product of the tryptophan and it can act as a stationary phase signal molecule that induces biofilm formation. Analysis of V. cholerae ∆dksA mutants showed severe growth defect in MM medium lacking amino acids. However, unlike E. coli ∆dksA strain, V. cholerae ∆dksA mutants initiated growth after 5-6 h and overnight incubation allowed the culture to reach into saturation 29 (unpublished observation) . Although the reason behind this is currently not clear, it could be due to excess (p)ppGpp production by the RelV protein of V. cholerae. It may be possible that accumulation of sublethal amount of (p)ppGpp could induce amino acid biosynthesis operons leading to growth even under dksA negative background. Thus, DksA also appears to be a pleiotropic regulator in V. cholerae, controlling stringent response, motility and virulence factor production ( Fig. 1) . Future studies are needed to unravel the exact regulatory functions of DksA in this important human pathogen.
Conclusion
Recent studies indicate that multiple genes are involved in modulation of stringent response in V. cholerae. Participation of RelA and SpoT enzymes along with the essential GTP binding protein CgtA in subtle regulation of intracellular levels of (p)ppGpp as well as the involvement of recently discovered novel synthetase RelV indicate that (p)ppGpp metabolism is highly complex in V. cholerae. Further, genetic evidences indicate that, as in the case with E. coli, the conserved regulatory protein DksA also modulates the action of (p)ppGpp in V. cholerae. Apart from stringent response regulation, DksA may also be directly or indirectly involved in virulence factor production and motility of V. cholerae. This could be due to overall effect of DksA on global transcription or by some other mechanism(s), which is yet to be elucidated. In summary, it appears that both RelV and DksA are fascinating proteins and further studies are needed to understand their role in fine tuning the regulation of gene expression in both pathogenic and non pathogenic organisms. Results: The JSF9 phage was found to kill classical strains and favour enrichment of El Tor strains, when mixtures containing strains of the two biotypes and JSF9 phage were subjected to alternate passage in infant mice and in samples of environmental water. Spontaneous derivatives of the classical biotype strains, as well as transposon mutants which developed resistance to JSF9 phage were found to be defective in colonization in the infant mouse model.
Interpretation & conclusions:
These results suggest that in addition to other factors, the inherent ability of El Tor biotype strains to evade predation by JSF9 or similar phages which kill classical biotype strains, might have enhanced the emergence of El Tor strains as the predominant pandemic biotype.
Key words Classical biotype -El Tor biotype -toxigenic Vibrio cholerae -vibriophage
in their competition for survival [1] [2] [3] . Toxigenic Vibrio cholerae, the causative agent of the epidemic diarrhoeal disease cholera, interacts with diverse phages, which can promote genetic diversity and/or cause selective enrichment of particular bacterial clones 2 .
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Historically, cholera is an ancient disease with the occurrence of seven distinct pandemics since the first pandemic of cholera recorded in 1817, but the disease still affects millions of people. V. cholerae O1 belongs to two biotypes, namely classical and El Tor which differ in certain phenotypic and genetic characteristics 4, 5 . The current 7 th pandemic of cholera which originated in Indonesia in 1961 is the most extensive in geographic spread and duration, and the causative agent is V. cholerae O1 of the El Tor biotype. The classical biotype, which caused the 6 th pandemic, is now presumably extinct. After a period during the 1970-1980 when both classical and El Tor strains coexisted, classical strains were last detected in southern Bangladesh in 1990 6 . However, factors associated with the replacement of the classical biotype as the predominant epidemic strain by the El Tor biotype, and eventual disappearance of the classical strains have not been adequately explained. The displacement of the classical strains by the El Tor might have been driven by undefined environmental forces to which the El Tor strains adapted more efficiently. For example, the propensity to form biofilms on aquatic surfaces, interactions with marine animals and plants, and the ability to resist acid production in carbohydrate metabolism are some of the possible determining factors [7] [8] [9] [10] in this ecological competition.
The recent recognition that phage predation may play a role in the natural control of cholera epidemics 2, 11, 12 reinforces prediction that changes in this pathogen may also be driven by phages. The emergence of certain strains are likely to be enhanced by phages through the bactericidal mechanism in which phage sensitive strains are killed while providing a selective advantage to phage resistant strains. Therefore, the ability to evade phage predation constitutes important development in attaining evolutionary fitness. In the present study, we describe a bacteriophage which could have contributed to the range of factors causing the replacement of the 6 th pandemic classical strains of V. cholerae with the El Tor strains causing the current 7 th pandemic. We have also attempted to reproduce the conditions using microcosms and animal models, under which one or more phages might have acted in the events leading to the replacement of the classical biotype strains by the El Tor strains.
Material & Methods
Bacterial strains and phages: V. cholerae strains used as indicators in plaque assays or host for phage preparations were from either clinical or environmental sources. Clinical strains were obtained from patients who attended the treatment center of the International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B) located in Dhaka or from the culture collection of ICDDR,B Environmental isolates were from surface waters in Dhaka. All V. cholerae strains were isolated between 1963 and 2009 and maintained in our collection.
Isolation and estimation of phage:
A panel of V. cholerae O1 were used as potential indicator strains to detect and isolate classical biotype specific phage from environmental water using the plaque assay, as described previously 2, 11 . Plaques were counted to estimate the concentration of phage particles in the sample. Phages from representative plaques were further purified, and the specificity of each phage was tested using a panel of strains belonging to different Vibrio species and serotypes. For detection and quantification of phage in intestinal extracts of mice, aliquots of the samples were pre-filtered through 0.22 µm pore size filters (Millipore Corporation, Bedford, MA) and dilutions of this filtrate were used in plaque assays. Animal studies were reviewed and approved by the Animal Experimental Ethics Committee of ICDDR, B.
Phage stability: The effect of temperature, pH, and salinity on the stability of JSF9 phage was assessed by adding a defined number of phage particles into SM buffer (100 mM NaCl, 8 mM MgSO 4 , 50 mM Tris-Cl, pH 7.5) adjusted to different conditions. The titre of phage particles remaining after 6 h was expressed as a percentage of the original titre.
Electron microcopy of phage particles:
A high titre phage preparation [~10 10 plaque forming unit/ml] was obtained using the plate lysis procedure as described previously 13 . The phage particle was negatively stained with 2 per cent uranyl acetate and was examined under a Philips transmission electron microscope (model 420T).
Determination of infectious dose (ID 50 ) in mice:
To determine the ID 50 of V. cholerae strains, 5-day-old Swiss Albino mice in groups of five were inoculated intragastrically with one or more laboratory grown V. cholerae strains, as well as with a mixture of V. cholerae and phage whenever appropriate. Aliquots of these samples were also cultured as described above to determine the cell count, and plaque assays were conducted to determine the concentration of phage. Mice were euthanized at 24 h and the small intestines were homogenized in phosphate buffered saline (PBS) pH 7.5. The homogenate was centrifuged and the pellet was re-suspended in fresh PBS, to eliminate possible phage particles (derived from phage positive samples) which could negatively influence the cell count. Dilutions of the suspension were then plated on taurocholate tellurite gelatine agar plates 14 (70 µg/ ml) to determine the number of colony forming units (cfu) of bacteria. The percentage of infected mice was plotted against the input dose to determine the ID 50 as described previously 15, 16 .
Competition assays in animals and in water samples:
To reproduce conditions under which phages might influence the selective enrichment or elimination of particular strains of pathogenic V. cholerae, we developed an assay system comprising repeated alternate inoculation of a mixture of V. cholerae strains and phage in animal models as well as in surface water samples. Competition assays were conducted by mixing 1:1 (v/v) ratio of the El Tor and classical biotype strains grown in Luria Bertini (LB) medium to log phase, and 10 6 plug forming units (pfu) of the classical biotype specific phage JSF9. Aliquots (50 µl) of a 1,00-fold dilution of this mixture, were administered to 3-5-day-old Swiss Albino mice. A control preparation of the bacterial mixtures without the phage was also used in each batch of assay. Mice were euthanized at 24 h and the small intestines were homogenized in PBS. The homogenate was inoculated in filter-sterilized environmental water samples (1:100 dilution), and incubated at room temperature for 24 h. Aliquots (50 µl) of this water samples were inoculated into a second batch of mice, and the process was repeated. After each passage, the relative concentrations of the two strains in the intestinal contents of mice, as well as in the water samples were determined by plating dilutions of the samples on nutrient agar plates containing an appropriate antibiotic. The V. cholerae strains could be differentiated by their antibiotic resistance property since the El Tor strains used were resistant to nalidixic acid, and the classical strains used were resistant to tetracycline or streptomycin. For phage positive samples, the presence of phage and the possible emergence of phage resistant derivatives of the classical V. cholerae strains was also monitored as described previously 17 .
Transposon mutagenesis: Transposon mutagenesis was conducted to create mutants of phage susceptible V. cholerae strains that became phage resistant. Mutation was done by mobilizing transposon pSC137 from the donor strain E. coli SM10λ pir to the recipient strain by mating using previously described methods 18 . The mutants were screened for susceptibility to JSF9 phage to select mutants that became phage resistant.
Results
General properties of JSF9 phage: The JSF9 phage was initially isolated from a sample of river water collected in Dhaka city, but are commonly found in different environmental water samples. The phage produced clear plaques with a diameter of approximately 1 mm on lawns of classical biotype V. cholerae O1 strains. When grown in LB with a classical biotype strain S224, the phage produced in the culture supernatant had a titre of ~10 8 pfu/ml. The specificity of the phage was examined using a panel of bacterial strains belonging to different Vibrio species or serogroups. Strains belonging to the classical biotype of V. cholerae O1 (Table I) were susceptible to the phage, whereas all other strains tested were clearly resistant.
We further examined whether the resistance of different V. cholerae strains to JSF9 phage was due to possible lysogeny of the phage in these strains, causing the bacteria to become immune to further infection by JSF9 phage. All strains listed in Table I , were probed with JSF9 phage DNA in colony blot hybridization. However, none of the strains tested were found to carry the JSF9 phage genome (data not shown).
Electron microscopic examination of JSF9 phage ( Fig. 1 ) revealed that the phage particle comprised of a hexagonal head (~45 nm) and a short tail (~5 nm), and thus morphologically belonged to the family Podoviridae
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. The genome of JSF9 phage consisted of a ~ 41 kb double stranded DNA. The phage was highly stable (75 to 95%) in a pH range between 3.0 and 9.0, and at temperatures below 37 o C. At temperatures above 50 o C, the phage particles were rapidly inactivated. JSF9 phage remained infectious for more than 10 wk when stored at room temperature in samples of filtersterilized surface water samples collected in Dhaka. These findings suggested that JSF9 phage may persist in the aquatic environment as infectious particles and act on susceptible V. cholerae strains.
El Tor biotype strains out-compete classical strains in the presence of JSF9 phage:
We conducted competition assays between pairs of El Tor and classical biotype strains (Table II) in the presence and absence of JSF9 phage. Assays were designed to reproduce likely conditions in environmental water and host intestinal milieu (infant mouse model) which pathogenic V. cholerae strains are presumed to experience in nature. In the absence of JSF9 phage, classical strains competed well and the cumulative competition index (CCI) of El Tor to classical strain at the end of two consecutive rounds of assays in mice ranged between 1.15 and 1.84 (Table II) , suggesting a somewhat better fitness of the El Tor strains. However, the relative fitness of El Tor strains was drastically enhanced when JSF9 phage was present, and the CCI ranged between 4.61 x 10 4 and 3.13 x 10 5 for different pairs of strains. Thus, the El Tor strains competed at least 10,000 fold better than classical strains in the presence of JSF9 phage.
To analyze whether the increase in the competition index was due to a difference in the infectivity of the two biotypes in the presence of JSF9 phage, we determined the ID 50 of the strains, a dose at which 50 per cent of challenged mice would be infected. This was done by inoculating various dilutions of log phase cultures into groups of mice with or without JSF9 phage. The mean ID 50 of the two groups of strains were found to be similar in the absence of the phage. However, in the presence of JSF9 phage, the ID 50 of the classical strains were ~10 fold higher (data not shown).
JSF9 phage resistant derivatives of classical strains are defective in colonization:
During the competition assays, spontaneous mutants of classical biotype strains resistant to JSF9 phage were detected. However, these mutants did not compete well with the El Tor biotype strains or the wild type classical strains in the mouse competition assay (Fig. 2) . Additionally, transposon mutagenesis was conducted in two JSF9 phage susceptible classical V. cholerae strains S224 and O395, to obtain mutants that became phage resistant and the JSF9 phage did not form plaques on a lawn of the mutants. Chromosomal sequence analyses of the transposon insertion sites revealed that mutants of classical biotype strains which became resistant to JSF9 phage infection and were no longer able to adsorb phage particles carried insertions in phospholipid and lipopolysaccharide biosynthetic genes. The gene Intestinal contents of mice from round-A of the assay was inoculated into aliquots of filter-sterilized environmental water and incubated for 6 h. In round-B of the assay mice were inoculated with fractions of this water. All classical strains isolated from mice after both rounds remained sensitive to JSF9; c For calculation of cumulative competition index for each set of assay the ratio of output counts of El Tor strain to classical strain in round-B was divided by the ratio of input counts of El Tor strain to classical strain in round-A encoding glycerol 3-phosphate acyltransferase (GPAT) was most frequently hit (4 of 7 mutants characterized) among the phage resistant mutants, followed by the gene encoding UDP-glucose-4-epimerase (3 of 7 phage resistant mutants). These mutants showed similar defect in the mouse colonization assay (Fig. 2) .
Discussion
Genetic and ecological factors which led to the elimination of the classical biotype of V. cholerae and promoted the emergence of the El Tor biotype strains have not been adequately explained. The evolutionary fitness of pathogenic strains of V. cholerae are presumed to be enhanced by their ability to amplify in the human host 4 . However, both classical and El Tor biotypes of V. cholerae O1 produce the major virulence factors responsible for human colonization and dissemination through diarrhoeal purge. Hence the evolutionary success of the 7 th pandemic clone over the pre-existing 6 th pandemic strains is likely to have been influenced by factors other than their virulence potential in humans.
Recent microarray based comparative genomics have led to the identification of two clusters of genes in the 7 th pandemic El Tor strains, known as the Vibrio seventh pandemic islands (VSP-1 and VSP-2) 20 . Although these genes have been speculated to have a role in environmental fitness of El Tor strains, the precise functions of the genes remains to be investigated. The inherent capability of El Tor biotype strains to resist acid production in carbohydrate metabolism has also been suggested to be a factor improving their fitness 10 . Studies have demonstrated that phages can significantly contribute to the distribution and abundance of different clones of V. cholerae 2, 11 . The present study was designed to investigate whether JSF9 or similar phages might have contributed to the events that led to the replacement of the 6 th pandemic classical strains by the 7 th pandemic El Tor strains by a bactericidal selective process.
Pathogenic strains of V. cholerae are known to transit between two different habitats. These include the host intestinal milieu and the aquatic environment, and in both these habitats the bacteria encounter different adverse conditions. The assay system in which V. cholerae recovered from the intestines of mice prechallenged with mixtures of the pathogens and the phage were inoculated into samples of environmental water, was designed to reproduce possible conditions under which the classical and El Tor strains might have competed for survival. Although in the absence of JSF9 phage, the classical biotype strains were able to compete with the El Tor biotype strains, the presence of JSF9 phage led the El Tor strains to out-compete the classical strains (Table II) suggesting clearly that JSF9 phage, in addition to possible other factors, could have markedly influenced the enrichment of El Tor strains and the elimination of classical strains.
Phage bacterial interactions appear to occur in both the aquatic environment and in the host intestine. Previous studies have shown that cholera victims excrete high titres of phage in their stools at a time that also correlates with the appearance of high concentrations of phage in nearby environmental waters 11 . Since pathogenic V. cholerae can grow rapidly in the host intestine, the host contributes significantly to the phage amplification by providing substrates for phage growth. Thus, host susceptibility to V. cholerae can influence phage-mediated selection of particular clones that are killed by the same phage once encountered in the extra-host environment 2, 11 . However, if a bacterial clone (e.g., the El Tor 7 th pandemic clone) is resistant to a phage that otherwise kills a competing clone (i.e., the classical biotype clone), then the ecological fitness of the former would triumph over the latter in any dynamic setting that amplifies both bacteria and phage, while supporting the killing of phage-susceptible clones. Such an environment clearly exists in cholera endemic areas such as Bangladesh 2, 11 . This strategy can result in elimination of the phage's substrate organism and in the end the phage as well, unless the phage has a secondary host. Perhaps this logic also explains the absence of many classical biotype specific phages in the Bangladesh environment, at the same time suggesting that JSF9 phage might have an alternative host.
The bacterial surface structure often used by phages as a receptor for adsorption to bacteria includes lipopolysaccharide O-antigen, outer membrane proteins, and pili. Since both classical and El Tor biotype strains share the same O1 antigen and most other surface structures, the ability of the El Tor strains to survive attack by JSF9 phage under conditions when classical strains are completely susceptible indicates that the receptor for JSF9 phage is probably absent from the El Tor strains, and this might have been the key to the selective emergence of the El Tor strain. It has been recognized previously that there are certain differences in the pattern of gene expression between the El Tor and classical biotypes of V. cholerae O1
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.
Although this study did not precisely identify the receptor for JSF9 phage infection, the observation that mutation in genes for glycerol 3-phosphate acyltransferase and UDP-glucose-4-epimerase confer phage resistance indicates a possible role of the bacterial LPS in JSF9 phage susceptibility. Alternatively, an OMP whose assembly in the membrane depends on lipid synthesis may also have a role. For example, in an Escherichia coli strain which is defective in glycerol-3-phosphate acyltransferase, a marked decrease of insertion of the bacteriophage Lambda receptor LamB protein occurs into the outer membrane 22 .
In conclusion, the results of this study suggest that the ability to resist predation by JSF9 or similar phages might have contributed to the evolutionary fitness of the V. cholerae El Tor biotype compared to that of the classical biotype both as a global cause of cholera and as an environmental organism.
Introduction
Discovery of effective agents to prevent and treat infections caused by pathogenic microorganisms has been one of the hallmarks of modern medicine. Antimicrobial agents are categorized according to their mechanism of action that include interference with cell wall synthesis (e.g., beta-lactams and Antimicrobials & cholera: are we stranded? Amit 
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Antimicrobial resistance poses a major threat in the treatment of infectious diseases. Though significant progress in the management of diarrhoeal diseases has been achieved by improved hygiene, development of new antimicrobials and vaccines, the burden remains the same, especially in children below 5 yr of age. In the case of cholera, though oral rehydration treatment is the mainstay, antimicrobial therapy is mandatory at times to reduce the volume of stool and shorten the duration of the disease. Though for many pathogens, antimicrobial resistance emerged soon after the introduction of antibiotics, Vibrio cholerae remained sensitive to most of the antibiotics for quite a long period. However, the scenario changed over the years and today, V. cholerae strains isolated world over are resistant to multiple antibiotics. A myriad number of mechanisms underlie this phenomenon. These include production of extendedspectrum beta-lactamases, enhanced multi-drug efflux pump activity, plasmid-mediated quinolone and fluoroquinolone resistance, and chromosomal mutations. Horizontal transfer of resistance determinants with mobile genetic elements like integrons and the integrating conjugative elements (ICEs), SXTs help in the dissemination of drug resistance. Though all strains isolated are not resistant to all antibiotics and we are not as yet "stranded", expanding spectrum of drug resistance is a definite cause for concern. Pipelines of discovery of new antibiotics are drying up as major pharmaceutical companies are losing interest in investing money in this endeavour, mainly due to the short shelf-life of the antibiotics and also due to the fast emergence of drug resistance. To address this issue, attempts are now being made to discover drugs which are pathogen specific and target their "virulence mechanisms". It is expected that development of resistance against such antibiotics would take much longer. This review briefly focuses on all these issues.
Key words Cholera -genetic elements -multidrug resistance -resistance genes -V. cholerae glycopeptide agents), inhibition of protein synthesis (macrolides and tetracyclines), interference with nucleic acid synthesis (fluoroquinolones and rifampin), inhibition of metabolic pathways (trimethoprimsulphamethoxazole), and disruption of bacterial membrane structure (polymyxins and daptomycin). becoming complicated, as many bacteria have become resistant to antimicrobial agents. The mechanism of resistance could be many; bacteria may be intrinsically resistant to these antimicrobial agents, or may acquire resistance through mutation or via the acquisition of resistance genes from other organisms. Acquired resistance genes may enable a bacterium to produce enzymes that destroy the antibacterial drug, to express efflux systems that prevent the drug from reaching its intracellular target, to modify the drug's target site, or to produce an alternative metabolic pathway that bypasses the site or pathways of the action of the drug. Acquisition of genetic material(s) by antimicrobialsusceptible bacteria from resistant strains may occur through conjugation, transformation, or transduction, with transposons that facilitates incorporation of the resistance genes into the host's genome or plasmids.
Soon after the discovery of antibiotics and their very successful application in medicine, antibiotic resistance started appearing in many microbes, however Vibrio cholerae continued to remain sensitive for a long period. In a worldwide survey carried out in 1976, only 3 per cent of the randomly collected strains were found to be resistant to commonly used antibiotics 1 . This scenario however, changed rapidly primarily due to the indiscriminate use of antibiotics. In a survey conducted in Bangladesh three years later, about 18 per cent of the "surveyed" strains were found to be resistant to a number of commonly used drugs 2 .
Pattern of antimicrobial resistance in V. cholerae is changing rapidly and some features are becoming well established. Based on several published works from National Institute of Cholera and Enteric Diseases, Kolkata, changing profile of resistance in V. cholerae is shown (Fig.) . This is not unique as many investigations conducted in different geographical areas have demonstrated an increase in the antimicrobial resistance spectrum among epidemically significant V. cholerae over time.
Furazolidone (Furoxone) was extensively used during late 1950s for the specific and symptomatic treatment of bacterial or protozoal diarrhoea 3 . This antibiotic was recommended for the treatment in children. However, from late 1980s, almost all the enteric pathogens developed resistance to this drug and though its application is now very limited, this trend is still continuing. Analysis of the antibiograms of V. cholerae O1 from various regions of the world between 1938 and 1993 showed resistance to 1 to 3 antimicrobials, whereas the strains isolated from 1994 to 2005 possessed 3 to 8 resistance markers including fluoroquinolones.
Strategies adopted by V. cholerae to combat antimicrobials (i) Resistance for quinolone and fluoroquinolone
In India and other countries, emergence of fluoroquinolone resistance has been reported from early 2000s as this drug was in extensive use for the treatment of different infectious diseases, including cholera. In many bacteria, resistance to the quinolones is generally associated with amino acid substitutions in portions of GyrA and ParC proteins called quinolone resistance-determining regions (QRDRs). Quinolone resistance in vibrios is mainly due to the occurrence of mutation in gyrA, which encodes a subunit of DNA gyrase, followed by mutations in parC, which encodes a subunit of DNA topoisomerase IV. In addition to the mutations in gyrA and parC, proton motive force-dependent efflux is also involved in quinolone resistance in clinical isolates of V. cholerae 4 . Extensive use of ciprofloxacin has compromised its effectiveness in many countries due to the decreasing susceptibility of V. cholerae.
(ii) Integrons
Integrons are naturally occurring gene acquisition systems which "help" bacteria capture exogeneous genes and incorporate them into their genomes 5, 6 . Integrons consist of a gene intI encoding a site-specific recombinase belonging to tyrosine-recombinase family called "integrase", a recombination site att1 into which the exogenous gene cassettes, harbouring the recombination site attC, are inserted through site-specific recombination and a promoter Pc, located within intI that drives transcription of the captured gene. Integrons play a prominent role in the dissemination of drug resistance because these frequently carry drug resistance genes and are often associated with mobile genetic elements. Based on the sequence of intI, integrons have been divided into five classes. Out of these, class 1 integrons are found widely among the clinical isolates of pathogenic bacteria. IntI integrase of class 1 integrons possesses all the features needed for performing recombination between att1 and attC, however, the rate of cassette recombination is controlled by the transcriptional repressor LexA 7 . Till date more than 100 different types of integron-borne gene cassettes, most of which code for antibiotic resistance, have been discovered. Out of these, only a limited few have been found in V. cholerae even though integrons have been detected in a large number of V. cholerae strains isolated all over the world 8 . Besides the five classes of integrons alluded to above, there exists another class called "Superintegrons". These are chromosomally located and are sedentary in the sense that these do not move. A superintegron was first discovered in V. cholerae but are now known to be present in many g-protobacteria 5 . Superintegrons harbour hundreds of genes but the functions of most of which are unknown. In V. cholerae O1, a few display significant homology to a number of drug resistance genes, suggesting that under appropriate conditions these could "become" drug resistance genes and confer upon its host the ability to express resistance phenotype. It may be mentioned here that in two strains of V. cholerae O1, one isolated in Brazil and the other in Vietnam, an integron borne qnr gene responsible for resistance to ciprofloxacin, have been detected 9, 10 .
(iii) Integrative and conjugative element (ICE)
The newly discovered integrating conjugative elements are movable linear DNA elements, which can integrate into bacterial genome and "move" through conjugation. These have the capacity to incorporate genes encoding many functions from drug-resistance to DNA repair pathways 11 . SXT in V. cholerae is an ICE, which carries resistance genes for sulphamethoxazoletrimethoprim, streptomycin and chloramphenicol l1 . SXT exconjugants may contain tandem SXT arrays and promote the formation of novel ICEs 12 .
The array formation appears to depend on conjugative transfer and is recA-independent. SXT excises from the chromosome to form a circular but non-replicative extrachromosomal molecule that is required for its transfer. The IncJ elements such as R391 are now found to be closely related to SXT 11 . Till date, more than 25 members of the SXT/R391 family of ICEs have been identified in environmental and clinical isolates of diverse species of gamma-proteobacteria worldwide.
The 100-kb ICE was first identified in a V. cholerae O139 clinical strain isolated in 1992 in India. Prior to the emergence of V. cholerae O139, SXT was rarely detected in O1 serogroup 13 . After the emergence of the serogroup O139, however, ICEs began to be detected frequently in Asian V. cholerae strains 11, 13 . Even among O139 strains, the SXT elements are not stably maintained and this results in periodic change in the strains in their resistance to sulphamethoxazoletrimethoprim, chloramphenicol, and streptomycin. SXT or closely related ICEs are now being reported in most clinical and some environmental strains of V. cholerae isolated in Asia and Africa. An SXTrelated ICE, ICEVchMex1 identified in a Mexican environmental V. cholerae isolate provided the first description of an SXT-related ICE in the Western Hemisphere
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. The significant difference between the SXT and ICEVchMex1 suggests that these ICEs evolved independently.
It was discovered by Beaber et al
15 that 'SOS response' can enhance the conjugative transfer of SXT by promoting the expression of genes necessary for the transfer of SXT through the inactivation of SetR, an SXT encoded repressor that keeps the transfer genes repressed. Ciprofloxacin which can induce SOS response was found to be able to promote the transfer of SXT and thus facilitate its dissemination. In other words, it was found that therapeutic agents too can aid in the spread of antibiotic resistance. Kim et al 10 found that ciprofloxacin activity is further compromised in strains habouring qnrVC3, which encodes a pentapeptide repeat protein of the Qnr subfamily as this protein protects topoisomerases from quinolone action. The gene qnrVC3 is present within a member of the SXT integrating conjugative element family found commonly on the chromosomes of multidrug-resistant strains of V. cholerae.
(iv) Extended-spectrum beta-lactamases
Beta-lactamase production could be demonstrated in 92.8 per cent of the ampicillin resistant V. cholerae strains isolated in south India 16 . The CTX-M-ases, which hydrolyze cefotaxime efficiently, are mostly encoded by transferable plasmids, and the enzymes have been found predominantly in many members of Enterobacteriaceae and V. cholerae 17 . The CTX-M-ases belong to the molecular class-A beta-lactamases, and the enzymes are functionally characterized as extendedspectrum beta-lactamases which confer resistance to penicillin, extended-spectrum cephalosporins, and monobactams. Class I integron-associated orf513 also seems to be involved in the mobilization of bla CTX-M genes. CTX-M-type, PER-2-type and TEM-1-like enzymes were identified in V. cholerae strains isolated from cholera cases in Argentina 18 . Plasmid profile analysis and Southern blotting revealed the presence of plasmids of about 150 kb with genes encoding CTX-M-type or PER-2-type ESBLs.
(v) Plasmids
One of the common modes of the dissemination of drug resistance is through the plasmids. V. cholerae O1 strains isolated before 1970s were susceptible to tetracycline. Subsequently, due to extensive use of this drug, resistance to tetracycline was reported in many African countries. Strains isolated in Angola cotransferred tetracycline and chloramphenicol phenotype to E. coli. Plasmids belonging to incompatibility group (Inc) C and J were detected in V. cholerae 19, 20 . Some of the V. cholerae O139 from India showed multidrug resistance. These strains harboured a 200 kb selftransmissible plasmid that mediated resistance to tetracycline, ampicillin, chloramphenicol, kanamycin, gentamicin, sulphamethoxazole and trimethoprim 21 . V. cholerae O1 El Tor isolated from patients in Uganda possessed a 130-MDa plasmid of incompatibility group 6-C that conferred resistance to trimethoprim (mediated by a dfrI gene), sulphonamides (suII), tetracycline (tetC) , chloramphenicol (catI), ampicillin (a beta-lactamase gene different from bla TEM or bla SHV ), and streptomycin 22 . This plasmid was transferred from V. cholerae to many other enteric bacteria indicating its potential to spread.
The emergence of pMRV150-like or pIP1202-like plasmids in many bacterial pathogens and nonpathogens in many geographical areas pose an increasing health risk, as these mediate antimicrobial resistance to at least six antibiotics, ampicillin, streptomycin, gentamicin, tetracycline, chloramphenicol, and trimethoprim-sulphamethoxazole 23 . The plasmid pMRV150 was being found with increasing frequency in V. cholerae O139 from Hangzhou, eastern China from 1994 onwards and was found to be similar to the plasmid pIP1202, an IncA/C plasmid detected in an MDR Yersinia pestis isolated from a bubonic plague patient in Madagascar 23 .
(vi) Efflux systems
Bacteria may acquire efflux pumps that export antibacterial agents before it can reach its target site and exert its effect. In V. cholerae, efflux pumps responsible for resistance to many antimicrobials have been demonstrated. In many Gram-negative bacteria, resistance to antimicrobial agents is mediated by resistance-nodulation-division (RND) family efflux systems. Deletion of six genes encoding RND efflux pumps from the genome of the V. cholerae O1 El Tor strain N16961 made this strain sensitive to multiple antimicrobial compounds, including bile acids, antimicrobial peptides and antibiotics 24 . Colmer et al 25 identified two open reading frames (ORFs) in V. cholerae with high degree of similarity with the conserved regions of the E. coli efflux pump proteins, EmrA and EmrB. NorM, a putative efflux pump of V. cholerae, is a member of the multidrug and toxic compound extrusion family of transporters. Singh et al 26 demonstrated that NorM confers resistance to norfloxacin, ciprofloxacin, and ethidium bromide. When the "selected" amino acids in the periplasmic and cytoplasmic loops of NorM was mutated, V. cholerae became hypersensitive towards norfloxacin, there-by showing the importance of NorM in norfloxacin resistance.
V. cholerae chromosome contains many putative genes of the multidrug and toxic compound extrusion (MATE) family. These include vcrM vcmB, vcmD, vcmH and vcmN 27 . Elevated MICs of multiple antimicrobial agents, such as fluoroquinolones, aminoglycosides, ethidium, etc. were observed in a drug hypersusceptible strain of E. coli when these genes were introduced into it through transformation. It was further shown that efflux activities of VcmB, VcmD and VcmH were Na+-dependent. Besides these, an operon VccCAB consisting of three genes involved in multiple-drug resistance (MDR) through efflux has been indentified in V. cholerae. This operon is negatively regulated by a transcriptional autoregulatory protein belonging to the TetR family of transcriptional regulators 28 . As mentioned earlier, there are six operons of putative RND-type efflux transporters present in the chromosome of V. cholerae O1. Out of these, vexAB, vexCD or vexEF together with tolC(Vc) of V. cholerae NCTC4716 elevated MICs of various antimicrobial agents when introduced into a susceptible E. coli strain 29 . Though all these efflux pumps have been studied well, epidemiological significance of these in the dissemination of drug resistance remains unexplored.
The current conundrum
From the general survey that has been provided the moot point that emerges is that V. cholerae possesses a myriad variety of mechanisms to combat antibiotics and that a stage may soon come when the use of commonly used antibiotics may cease to become effective. Though it is not true that all strains everywhere are resistant to all antibiotics or there is no antibiotic available which could be effective against a recalcitrant strain, patterns of antibiograms of the recently emerging strains are a cause of great concern. If one examines the antibiotic "scenario" today, one finds that all antibiotics developed till date are targeted against only a few bacterial functions or enzymes and there too not all potential targets are targeted. For example, even though nineteen genes are known to be essential for DNA replication, only five are targeted.
This scenario, however, appears to be changing and "new" targets are being explored. Thus for example, in very recent times, a few promising lead molecules specific for V. cholerae have been obtained. One such molecule is Vibrepin 30 . In vibrios, replication of the smaller chromosome depends on rctB; Vibrepin, acts against V. cholerae by blocking RctB oriCII unwinding leading to the formation of large non-functional RctB complexes. Although Vibrepin appears to have targets other than RctB also, findings of Yamaichi et al 30 suggest that RctB could be an attractive target for the generation of novel antibiotics specific to vibrios. The efflux pump inhibitors (EPIs) 1-(1-naphthylmethy1) piperazine (NMP) and phenylarginine-betanaphthylamide (PAbetaN) are found to inhibit V. cholerae resistance-nodulation-division (RND) family efflux systems, hereby rendering the organism susceptible to antimicrobial agents. These were also found to inhibit the production of the virulence factors such as cholera toxin (CT) and the toxin coregulated pilus (TCP) 31 . Hence, one can think of developing RND efflux inhibitors as novel therapeutic agents for the treatment of cholera.
Thus in principle, there is considerable scope for the development of new antibiotics to combat drug resistance. In reality, however, it remains a doubtful proposition. Currently prevailing situation in the pharmaceutical industry makes it unlikely that a pharmaceutical company will spend millions in such an endeavour. A pharma company's decision to invest in drug development is dictated by a parameter known as "Net Present value" (NPV) 32 . Any drug with an NPV less than 100 is usually not taken up for further development. NPV for an antibiotic is 100, whereas that for a muscular-skeletal drug is 1150 33 . Antibiotics which are on the borderline is, therefore, are not attractive as investment targets. Indeed, it is seen that in the recent years there has been a sharp decline in the number of pharmaceutical companies engaged in research and development in the area of antibiotics.
Possible way out: Future directions
One of the major reasons why the investment in the research and development of new antibiotics is not an attractive financial proposition is the potentially limited clinical life span of antibiotics due to rapid development of resistance against them. Several measures to tackle this menace have been proposed-a prominent one being restricted use of antibiotics. However, a recent study has shown that this strategy may not be very effective in the long run. During a seven month period in 2001-2002 use of ciprofloxacin was restricted in Israel. Gottesman and his colleagues 34 at Tel Aviv University measured ciprofloxacin sensitivity of E. coli isolated from urine, before, during and after this period. About 50 per cent reduction in ciprofloxacin use reduced the percentage of samples containing ciprofloxacin resistant bacteria from 12 to 9 per cent. But as soon as the restriction was lifted, a resurgence in the number of resistant bacteria occurred. Limited usefulness of this strategy pointed to the need for the exploration of other methods. A possible way could be to test an already developed antibiotic, untested against a particular pathogen, for its effectiveness against that pathogen. Feasibility of such an approach is demonstrated by the fact that antibiotic sitafloxacin, which has not been used in the treatment of cholera so far, has been found to be 4-6 fold more potent against V. cholerae, compared to ciprofloxacin, ofloxacin, sparfloxacin and levofloxacine in in vitro studies, suggesting that it can probably be used in the treatment of cholera caused by fluoroquinolone resistant strains of V. cholerae 35 . This approach too does not provide a satisfactory solution as with time bugs will develop resistance against these antibiotics also. Therefore, to minimize the possibility of rapid development of drug resistance, an altogether different approach is being explored. Detailed knowledge of virulence mechanisms in many bacterial pathogens accumulated during the past two decades has led to the invention of a new class of antibiotics that target the virulence mechanism in such pathogens 36 . As these antivirulance drugs are pathogen-specific, their use are expected to be much more limited than the commonly used broad-spectrum antibiotics and therefore, it is expected that in the development of resistance against such antibiotics would take much longer 37 . Guided by such considerations and using a high-throughput phenotypic screen that inhibits virulence regulation, a small molecule 4-[n- (1,8-napthalimide] -n-butyric acid (designated Virstatin) has been identified 38 . By inhibiting the transcriptional regulator ToxT, Virstatin prevents expression of two critical virulence factors in V. cholerae namely, the cholera toxin (CT) and the toxin coregulated pilus (TCP) and thus renders it "avirulant". Further, it has been seen that orogastric administration of virstatin protects infant mice from intestinal colonization of V. cholerae. Though the clinical efficacy of virstatin has not yet been explored, in principle at least it, opens up an avenue for the discovery of more such molecules.
Spread of antibiotic resistance has been recognized by the WHO as an extremely serious problem as it complicates the treatment of infectious diseases enormously. Therefore there is an urgent need to fight the spread of antibiotic resistance. If all the factors that have been mentioned are considered, it becomes apparent that perhaps a combination of conventional antibiotics and the antivirulence drugs, along with the "restricted" use of already available antibiotics, could turn out to be most effective method in arresting the explosive growth of drug resistance that is plaguing the world today. In this respect, several strategies were proposed at international and regional levels 39, 40 .
Introduction
Cholera is an acute diarrhoeal disease which is characterized by discharge of voluminous rice water stool caused by toxigenic Vibrio cholerae strains. V. cholerae O1 and O139 serogroups producing cholera The rise in multi-drug resistant Vibrio cholerae strains is a big problem in treatment of patients suffering from severe cholera. Only a few studies have evaluated the potential of natural compounds against V. cholerae. Extracts from plants like 'neem', 'guazuma', 'daio', apple, hop, green tea and elephant garlic have been shown to inhibit bacterial growth or the secreted cholera toxin (CT). However, inhibiting bacterial growth like common antimicrobial agents may also impose selective pressure facilitating development of resistant strains. A natural compound that can inhibit virulence in V. cholerae is an alternative choice for remedy. Recently, some common spices were examined to check their inhibitory capacity against virulence expression of V. cholerae. Among them methanol extracts of red chili, sweet fennel and white pepper could substantially inhibit CT production. Fractionation of red chili methanol extracts indicated a hydrophobic nature of the inhibitory compound(s), and the n-hexane and 90 per cent methanol fractions could inhibit >90 per cent of CT production. Purification and further fractionation revealed that capsaicin is one of the major components among these red chili fractions. Indeed, capsaicin inhibited the production of CT in various V. cholerae strains regardless of serogroups and biotypes. The quantitative reverse transcription real-time PCR assay revealed that capsaicin dramatically reduced the expression of major virulence-related genes such as ctxA, tcpA and toxT but enhanced the expression of hns gene that transcribes a global prokaryotic gene regulator (H-NS). This indicates that the repression of CT production by capsaicin or red chili might be due to the repression of virulence genes transcription by H-NS. Regular intake of spices like red chili might be a good approach to fight against devastating cholera.
Key words Capsaicin -cholera toxin -real-time PCR -spice -Vibrio cholerae toxin (CT) are mainly responsible for cholera outbreaks that can cause havoc in highly populated regions in Asia, Africa, and Latin America 1 . V. cholerae O1 is further divided into El Tor and classical biotypes. The ongoing pandemic of cholera that started in 1961 is caused by O1 El Tor biotype, which replaced O1 classical strains that Review Article 232 caused previous six pandemics. The O139 serogroup evolved as a new epidemic strain in 1992 2 . Currently, the El Tor variant strains possessing classical type ctx genes are mainly responsible for cholera outbreaks in many developing countries 3 . Strains of V. cholerae, which do not belong to O1 or O139 serogroups are commonly called as non-O1/non-O139, some of them are toxigenic and can cause sporadic cases of diarrhoea 4 . In serious cases, the infection can produce an acute state of dehydration within several hours and if untreated, can be fatal. Among various virulence factors reported in V. cholerae, CT (encoded on a filamentous phage called CTX-Ф) consisting of one A and five B subunits and the toxin co-regulated pilus (TCP) are the most important factors associated with severity of the illness. TCP can act as a receptor for CTX-Ф and also aid in bacterial colonization in our intestine 5 .
Oral rehydration solution (ORS) is a commonly used therapy for cholera that aids recovery from dehydration. However, due to the severity of the disease, antimicrobial agents are most often administered in addition to intake of ORS. Unfortunately, through mutation and the selective pressure exerted by the antimicrobial agents, V. cholerae strains have been increasingly becoming resistant to commonly used antimicrobial agents. In the past two decades, most of the V. cholerae strains in cholera endemic countries have become resistant to many antimicrobial agents including tetracycline, ampicillin, nalidixic acid, streptomycin, sulphonamides, trimethoprim, gentamicin, ciprofloxacin etc. [6] [7] [8] . The emergence and spread of multi-drug resistant (MDR) pathogenic bacteria have created the need for the development of novel therapeutic agents. Conventional antimicrobial agents are generally bacteriocidal or bacteriostatic which may foster the development of MDR strains. Alternatively, inhibiting bacterial virulence factor by natural compounds is a new approach to overcome increased antimicrobial resistance in pathogenic bacteria. Commonly used natural products like spices, herbs, fruits, etc. have many kinds of beneficial effects to our health. In India, Ayurveda, a comprehensive medical system that utilizes natural products, has been used to cure many diseases including diarrhoea since ancient time. Spices and herbs have also been traditionally used to treat diarrhoeal diseases in other parts of the world. Natural products have less side effects and thus advantageous for therapeutic purpose. Recently, we have observed that extracts from some common spices can repress CT production in V. cholerae. Natural compounds, which can directly inhibit virulence gene expression in V. cholerae, may be used along with intake of ORS for treating devastating cholera.
Plant products as remedy for diarrhoea
The beneficial health effects of many plants, used for centuries as seasoning agents in food and beverages, have been claimed for not only preventing food deterioration but also acting as antimicrobials against pathogenic microorganisms. A few studies have been carried out in a systematic manner, although phytochemical and pharmacological investigations of several plants have already led to the isolation of some of the natural antimicrobials 9 . Scientists are searching for natural products that can be used in large scale to reduce diarrhoea caused by vibrios. Some natural compounds have been examined to act against bacterial growth whereas little is known about specific influence on their virulence regulation.
The use of natural products as medicine has dramatically increased in the last two decades. Wasabi (Wasabi japonica), a traditional spice used with raw fish (e.g., sushi) in Japan, has been shown to have antimicrobial effect against some bacteria including V. parahaemolyticus 10 . Among the natural compounds possessing antimicrobial activity, a few have been tested against V. cholerae. Japanese green tea (Camellia sinensis) has been shown to inhibit both the growth and CT expression of V. cholerae in experimental animal 11 . Some plant polyphenols (e.g., procyanidins, gallate analogues, apelphenon, etc.) can also suppress CT activity in rabbit ileal loop or by repressing its binding to the Vero and CHO cells [12] [13] [14] [15] . However, these polyphenols can act on the purified or extracellular CT but not on virulence expression of V. cholerae. Extracts from 'neem' (Azadirachta indica) and 'elephant garlic' have also been shown to inhibit V. cholerae growth 16, 17 . However, any kind of antimicrobial agent targeting bacterial viability may impose selective pressure facilitating development of antimicrobial resistance. Red bayberry has the potential to inhibit the CT production in V. cholerae at sub-bacteriocidal concentration 18 . We have recently identified that red chili and one of its active compounds called capsaicin can inhibit CT production in V. cholerae without affecting bacterial growth 19 . This kind of compounds inhibiting virulence expression may impose less selective pressure on the development of antimicrobial resistance 20 . A list of natural compounds so far identified to act against diarrhoeagenic vibrios is shown in Table I .
Inhibition of CT production in V. cholerae by spice extracts
Some spices (e.g., red chili, sweet fennel, pepper, cassia bark, etc.) are known to act as anti-inflammatory, anticancer, antimicrobial or antifungal agents 21, 22 . However, there is very limited knowledge on the effect of spices on virulence regulation in pathogens. Ginger has been reported to block the heat-labile enterotoxin in Escherichia coli 23 . We have recently examined whether some spices contain any compound which can inhibit the virulence expression of various V. cholerae strains, in particular, recently emerged V. cholerae O1 El Tor variant 19 . Some culinary spices, which are commonly available in cholera endemic countries in South East Asia and age cost-effective were selected for this purpose.
Initially, four V. cholerae El Tor strains belonging to the recently emerged El Tor variant were tested against methanol extracts of red chili, sweet fennel, white pepper, red pepper, cassia bark and star anise. Spices were ground to fine powder and extracted with 99.9 per cent methanol and added to bacterial culture after appropriate dilutions. The selected strains were cultured at 37ºC in AKI medium, pH 7.4 24 with and without methanol extract of each spice. Cell free culture supernatant (CFS) was prepared by centrifugation followed by filtration through 0.22 μm filter. CT was purified as described previously 25 and used as a control to quantify the concentration of CT in cultures using a previously established bead enzyme-linked immunosorbent assay (bead-ELISA) 26 . Before CFS preparation, each culture was serially diluted with phosphate buffer saline (PBS) and spread on Luria Bertani (LB) agar (Difco, KS, USA). Numbers of colonies were counted after overnight incubation at 37ºC. It was observed that all the spices extracts (each 100 µg/ml) had high inhibitory activity against CT production in most of the cases (Table II) . Red chili, sweet fennel and white pepper showed comparatively higher inhibitory effect (>80%) against CT production in V. cholerae strains than other spices 19 . The inhibitory effect on CT production in V. cholerae varied from strain to strain, e.g., 45-86 per cent inhibition with cassia bark and 53-80 per cent inhibition with red pepper extracts. Star anise extract had lower inhibitory effect (6-66%) on CT production when compared to other spice extracts (our unpublished data). The spice extracts (100 µg/ml) did not show any impact on bacterial growth during 1, 2, 4 and 8 h sampling time (data not shown). Among the six spices, red chili methanol extract showed potential inhibitory effect against CT production in V. cholerae. Red chili is an easily available natural spice and commonly used in cholera endemic regions like India and other countries in South-East Asia and Africa. The red chili extract was fractionated to purify and identify the active compounds, firstly, with aqueous/ethyl acetate mixture, then the aqueous extract was further fractionated with n-butanol while the ethyl acetate extract was further fractionated with n-hexane and 90 per cent methanol. When all these extracts were applied to the culture of a representative El Tor variant strain (CRC41), most of the inhibitory activity against CT production was detected in n-hexane and 90 per cent methanol extracts although weak inhibitory activity was also observed in other extracts (Fig. 1) . The nature of such compounds responsible for CT inhibitory effect could be hydrophobic. Similarly, 90 per cent methanol extracts of sweet fennel and white pepper also showed high inhibitory effect on CT production (our unpublished data). Further fractionation of n-hexane and 90 per cent methanol extracts of red chili by silica gel and thin layer chromatography revealed that the fractions with strong inhibitory activity against CT production contained capsaicin 19 , a major component of red chili and mixture of fatty acids (our unpublished data). The inhibitory effects against CT production by both of these components were verified (Fig. 1) . It has been reported that some fatty acids or their derivatives from microorganisms or plants are also sources for antimicrobial agent 27, 28 against Gram-positive as well as Gram-negative bacteria 29 . Recently, the role of unsaturated fatty acid from bile source to inhibit CT production in V. cholerae classical strain has been illustrated 30 .
Efficacy of capsaicin as inhibitory agent against CT production
Capsaicin (N-anillyl-8-methyl-nonenamide) is one of the active ingredients in red chili which can act as an antimicrobial agent against bacterial pathogens such as Bacillus spp., Helicobacter pylori, etc. 31, 32 . Besides, use of natural compounds like red chili or its derivatives like capsaicin as food supplement is advantageous because it is not harmful to common flora in human intestine 32 . Recently, we have extensively studied inhibitory activity of capsaicin on CT production in V. cholerae strains collected in various countries and years from 1948 to 2006 19 . Twenty three V. cholerae strains belonging to various serogroups and CT genotypes were selected. The ctxB genotyping of the selected strains was performed by mismatch amplification mutation (MAMA)-PCR assay 33 . It was observed that capsaicin could inhibit CT production in all kind of toxigenic V. cholerae strains, i.e., strains belonging to El Tor variant, El Tor, classical, O139 as well as non-O1/non-O139 (Fig. 2) . Furthermore, we also observed that capsaicin inhibited CT production in a dose-dependent manner. Capsaicin could inhibit CT production strongly in all strains without affecting their growth, e.g., in case of El Tor strains (n=5) the inhibition was 70-99 per cent, in case of the recently emerged El Tor variant strains (n=12) producing classical type CT it was 90-99 per cent, in case of classical strains (n=2) it was 78-90 per cent, in case of O139 strains (n=2) it was 85-95 per cent and in case of CT-producing non-O1/non-O139 strains it was 90-95 per cent (Fig. 2) .
Recent cholera epidemics predominantly caused by the El Tor variant strains in many developing countries is a matter of concern because of the higher pathogenic potential of these variant strains 3, 34 . One of the reasons could be higher CT production by El Tor variant strains possessing classical ctxB gene allele than typical El Tor 35 . The result of our study also showed similar trend, i.e., higher CT production among El Tor variant strains 19 . However, our results indicate that the inhibitory impact of capsaicin is not influenced by the amount of CT production by various V. cholerae strains. Importantly, capsaicin can effectively inhibit YAMASAKI et al: NATURAL COMPOUNDS & V. CHOLERAE 235 Fig. 1 . Effect of spices extracts and its purified compounds on cholera toxin production of V. cholerae. V. cholerae O1 El Tor variant strain CRC41 was cultured in AKI medium in the presence of extracts of various solvents from red chili methanol extract. Identified compounds (capsaicin and fatty acid mixture) after fractionation (by thin layer chromatography) of red chili methanol extract were also tested.
Comparative inhibition of CT production by methanol extracts of sweet fennel and white pepper are also shown. The amount of CT production is represented by mean ± SD.
CT production not only in El Tor variants but also in typical El Tor, O139, classical as well as in non-O1/ non-O139 strains (Fig. 2) 
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Inhibition of transcription of virulence and regulatory genes of V. cholerae by red chili and capsaicin
Expression of CT and TCP is activated by the expression of ToxT which in turn is regulated by TcpP/TcpH and ToxR/ToxS 36, 37 . On the contrary, histone-like nucleoid structuring protein (H-NS) encoded by the hns gene, a global prokaryotic gene regulator, has been shown to repress the transcription of several virulence genes including toxT, ctx and tcpA 38 . To analyze the inhibitory mechanisms of red chili or one of its major components capsaicin on CT production in V. cholerae strains, quantitative reverse transcription real time PCR (qRT-PCR) analysis was performed using a representative strain belonging to V. cholerae O1 El Tor variant. This strain was grown with and without red chili extract or capsaicin. Total RNA was extracted and qRT-PCR was performed following TaqMan probe method. Red chili extract repressed the transcription of ctxA gene more than 43-fold (P<0.01) whereas capsaicin repressed it about 23-fold (P<0.01) (Fig. 3) 19 . The influence of capsaicin (100 µg/ml) was further checked targeting transcription of tcpA, toxT, toxR, toxS, tcpP, tcpH and hns genes 19 . Transcription of some of these genes was also repressed by capsaicin, e.g., tcpA (6.3-fold; P<0.01) , toxT (4.0 fold; P<0.01), tcpP (2.7 fold; P<0.05) and tcpH (2.5-fold; P<0.05) (Fig.  3) . Interestingly, transcription of hns was enhanced more than two times by capsaicin (P<0.01) 19 . In the qRT-PCR assay the transcription of recA, a housekeeping gene used as control, was not affected in the presence or absence of red chili extract and capsaicin.
Reduction in the transcription of ctxA, tcpA and toxT genes in the presence of capsaicin may be due to the inhibitory effect of capsaicin on ToxT (Figs 3 and  4) . Previous study has also reported that a synthetic compound virstatin (4-[N-(1,8-naphthalimide) ]-n-butyric acid) can inhibit CT production in a ToxT dependent manner 39 . However, it has been shown earlier that H-NS negatively regulates the transcription of toxT, ctx and tcpA genes 38 . Another study has demonstrated that in the presence of bile hns can also repress ctx and tcpA transcriptions in a ToxT independent manner 30 . As capsacin could enhance hns gene transcription (Fig. 3) , it is plausible that hns may play a critical role in the reduction of transcriptions of ctxA and tcpA 19 . Therefore, capsaicin may directly or indirectly activate the hns transcription which in turn downregulates the (Fig. 4) . In case of the transcription of toxR/toxS regulatory genes capsaicin had no impact but the compound repressed tcpP/tcpH transcription (Fig. 3) . ToxR is believed to instigate CT production by inducing toxT transcription via synergistic coupling of ToxR/ ToxS and TcpP/TcpH 37 . These data suggest that capsaicin could repress transcription of virulence genes via induction of hns in a ToxR-independent manner (Fig. 4) . However, red chili extract showed higher inhibitory impact in comparison to capsaicin which indicates the possibility of having other unidentified compound(s) in red chili that can directly inhibit or synergistically act with capsaicin. We have noticed that fatty acid mixture fraction of red chili extract can also inhibit CT production ( Fig. 1) . Further studies regarding the purification of other active compound(s) present in red chili and other spices extracts as well as in vivo study with sub-bacteriocidal concentration of spices extracts are ongoing in our laboratory.
Conclusion
Various natural compounds can be used to treat cholera in parallel to the conventional therapeutic agents. Particularly, spices like red chili, white pepper and sweet fennel can inhibit CT production in V. cholerae. As these spices act against virulence expression rather than the viability of V. cholerae there is less chance of developing resistance. One of the active compounds present in red chili is capsaicin, which can inhibit CT production in V. cholerae strains regardless of their serogroups and biotypes. The inhibitory mechanism of CT production by capsaicin is probably due to the H-NS mediated inhibition of the transcription of major virulence genes such as ctx and tcpA genes. Regular intake of commonly available and inexpensive spices (especially, red chili, sweet fennel and white pepper) can be a possible approach to reduce the disease vulnerability from V. cholerae. These are primarily opinion pieces written by senior scientists, public health experts and policy makers. Such papers will be by a single author. No anonymous articles will be published. They should be about 1000-1500 words and may contain References. Except for commissioned pieces, all submissions will be published subject to peer review.
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